1) You may have mis-typed the URL. Try checking your spelling and then click refresh.
2) It's possible the content you're looking for has moved. Try using the search form a the top of the page.
1) You may have mis-typed the URL. Try checking your spelling and then click refresh.
2) It's possible the content you're looking for has moved. Try using the search form a the top of the page.
Hypersensitivity reactions, including anaphylaxis, may occur. Signs may include angioedema, chest tightness, difficulty breathing, wheezing, urticaria, and itching. Discontinue Rebinyn® if allergic or anaphylactic type reactions occur and initiate appropriate treatment.
Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated, is a recombinant DNA derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B for on-demand treatment and control of bleeding episodes and perioperative management of bleeding.
Limitations of Use: Rebinyn® is not indicated for routine prophylaxis or for immune tolerance induction in patients with hemophilia B.